Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:CBM

Cambrex (CBM) Stock Price, News & Analysis

Cambrex logo

About Cambrex Stock (NYSE:CBM)

Advanced Chart

Key Stats

Today's Range
$59.99
$59.99
50-Day Range
$59.99
$59.99
52-Week Range
$33.80
$60.29
Volume
N/A
Average Volume
218,726 shs
Market Capitalization
$2.02 billion
P/E Ratio
21.66
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cambrex and its competitors with MarketBeat's FREE daily newsletter.

CBM Stock News Headlines

One stock to replace Nvidia
Investing Legend Hints the End May be Near for These 3 Iconic Stocks One company to replace Amazon… another to rival Tesla… and a third to upset Nvidia. These little-known stocks are poised to overtake the three reigning tech darlings in a move that could completely reorder the top dogs of the stock market. Eric Fry gives away names, tickers and full analysis in this first-ever free broadcast.
China CBM Group Co Ltd 08270
See More Headlines

CBM Stock Analysis - Frequently Asked Questions

Cambrex Co. (NYSE:CBM) posted its quarterly earnings data on Thursday, August, 2nd. The biotechnology company reported $0.74 EPS for the quarter, topping the consensus estimate of $0.69 by $0.05. Cambrex's quarterly revenue was up 13.0% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cambrex investors own include Bristol Myers Squibb (BMY), Illumina (ILMN), AbbVie (ABBV), Meta Platforms (META), CVS Health (CVS), Gilead Sciences (GILD) and NVIDIA (NVDA).

Company Calendar

Last Earnings
8/02/2018
Today
8/08/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Life Sciences Tools & Services
Current Symbol
NYSE:CBM
CIK
820081
Fax
N/A
Employees
1,732
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
$2.77
Trailing P/E Ratio
21.66
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$92.41 million
Net Margins
5.96%
Pretax Margin
N/A
Return on Equity
5.38%
Return on Assets
2.50%

Debt

Debt-to-Equity Ratio
0.76
Current Ratio
2.37
Quick Ratio
1.70

Sales & Book Value

Annual Sales
$532.09 million
Price / Sales
3.80
Cash Flow
$3.91 per share
Price / Cash Flow
15.36
Book Value
$19.48 per share
Price / Book
3.08

Miscellaneous

Outstanding Shares
33,720,000
Free Float
N/A
Market Cap
$2.02 billion
Optionable
Optionable
Beta
2.14
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:CBM) was last updated on 8/9/2025 by MarketBeat.com Staff
From Our Partners